The recent advances in the host targets of anti-influenza drugs.
- Author:
Lin-Lin MA
;
Jian-Dong JIANG
;
Yu-Huan LI
- Publication Type:Journal Article
- MeSH:
Anti-Inflammatory Agents;
pharmacology;
Antiviral Agents;
pharmacology;
Humans;
Immunity, Innate;
Influenza, Human;
drug therapy;
Virus Replication
- From:
Acta Pharmaceutica Sinica
2014;49(12):1631-1638
- CountryChina
- Language:Chinese
-
Abstract:
The challenge of the emergence of drug-resistant influenza strains, which is caused by wide spread utilization of direct-acting antivirals (DAAs), accelerates the research and exploration towards host targeted agents. In contrast to DAAs targeting viral replication components, host targeted agents, which regulate host factors and pathways linked to viral replication, can interfere the replication of influenza. Additionally, the innate immune system is activated by influenza during the early stage of infection, so manipulating the innate immune response may prevent the viral infection. However, the excessive inflammatory response induced at the late phase of influenza infection would lead to severe tissue injures. Thus, it is very important to explore drugs with anti-inflammatory actions to suppress these immune imbalances and tissue injures. Here we overview the current progresses about host targets related to anti-influenza drugs.
